It is very exciting to see the FDA authorized Dr. Wallach and his research! Dr. Wallach is owner of Youngevity Nutrition, Health, Wellness, Mineral Makeup, SPA and Skin Care. He has proven to the FDA his claim that Selenium may reduce the risk of certain cancers. It is now on record that scientific evidence suggests that consumption of Selenium may reduce the risk of certain forms of cancer.

This is HUGE considering our FDA does not typically endorse nutritional claims without some heavy research proving such claims. The FDA did go on to say that the evidence is limited and not conclusive. What this means is researchers like myself need to continue working hard to bring the FDA more EVIDENCE!!

The FDA endorsed the evidence that Selenium may create an anti-carcinogenic effect in the body. "Scientific evidence suggests that consumption of Selenium may produce anti-carcinogenic effects in the body" .

﻿Another very exciting study was done by South Carolina's own CLEMSON UNIVERSITY! Clemson is one of the nation's most prominent and respected academic institutions. The Institute of Nutraceutical Research (INR) is the national leader in nutritional research and one of its missions is to provide consumers greater confidence in product quality, safety, and efficacy. INR is focused on using its vast knowledge base, innovation and cutting-edge technology, and experience to accurately assess the value of various ingredients and Nutraceuticals. ﻿

Youngevity contracted Clemson University's Institute of Nutraceutical Research to identify the potential benefits of two of its products, Beyond Tangy Tangerine and Ultimate Classic. Youngevity's mission was to truly understand and clinically substantiate the health promoting benefits of these two products. Using Clemson INR as a complete 3rd party researcher and academic university with no direct relationship, Youngevity sought a fully unbiased perspective and evaluation of their products.

Multiple studies were done by the Clemson scientists to provide a comprehensive evaluation of the Youngevity products. Specific biomarkers were chosen to study in the areas of Safety, Inflammation, and the treatment of various Cancer Cells.

The studies done at Clemson University were not human trials but were called "bench" or "test tube" or "in vitro. Youngevity and Clemson University Institute of Nutraceutical Research are excited to report the positive findings.

1. Beyond Tangy Tangerine and Ultimate Classic both exhibited efficient inhibition on proliferation of cancerous cells at the recommended dosage levels. The evaluations, were carried out multiple times to confirm the results. Both products showed there was inhibition of the growth of more cancerous cells, preventing further malignant multiplication and growth of unhealthy cells.

2. In the presence of inflammation, Beyond Tangy Tangerine increased the levels of IL-6. This means that the cell line was able to increase its levels of the natural signaling immunomodulator to enhance the immune response by administrating Beyond Tangy Tangerine. Beyond Tangy Tangerine was able to repress the IL-6 production of LPS; repressing the increased amount of inflammatory response. What this means is the product helps calm down inflammation. 3. When Beyond Tangy Tangerine and Ultimate Classic were administered to healthy human cell lines, they did not induce or create ANY inflammatory response.